Liver Volume Variation Effect on SBRT Planning and Delivery for Upper Abdominal Malignancies
NCT06355895 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2025-08-07
Summary
Standard planning constraints for liver SBRT incorporate strict dose-volume limits for normal liver parenchyma to minimize the risk of radiation-induced liver disease. The presence of diurnal and fasting/fed variations in liver volume therefore carry substantial potential for introducing errors into estimates of dose-volume distribution within normal liver tissue, as well as affecting day-to-day setup fidelity and organ alignment for treatment. This prospective study will examine how diurnal and fast-fed variations in liver volume affect treatment planning for abdominal SBRT.
Conditions
- Upper Abdominal Malignancies
Interventions
- DIETARY_SUPPLEMENT
-
Standardized high-carbohydrate meal
8 ounces of Ensure® nutritional protein shake or a similar meal
Sponsors & Collaborators
-
American College of Radiation Oncology
collaborator UNKNOWN -
University of Pittsburgh
lead OTHER
Principal Investigators
-
Susannah Ellsworth, MD · UPMC Hillman Cancer Center
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-16
- Primary Completion
- 2026-03-31
- Completion
- 2026-03-31
Countries
- United States
Study Locations
More Related Trials
-
OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases
NCT04020276 ·Status: RECRUITING ·Phase: NA
-
Stereotactic Body Radiation Therapy (SBRT) for Liver Mets
NCT01360606 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation
NCT00178243 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer
NCT02683200 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Stereotactic Radiation Therapy in Treating Patients With Liver Metastases
NCT00567970 ·Status: COMPLETED ·Phase: PHASE1
-
Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer
NCT04745390 ·Status: RECRUITING ·Phase: NA
-
SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant Waitlist
NCT03950102 ·Status: UNKNOWN ·Phase: NA
-
SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma
NCT01357525 ·Status: COMPLETED ·Phase: NA
-
Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic Cancer
NCT01342354 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.
NCT05946824 ·Status: RECRUITING ·Phase: PHASE2
-
Functional Liver After SBRT
NCT07033364 ·Status: RECRUITING
-
HCC Response Assessment by MRI After SBRT
NCT03088423 ·Status: COMPLETED
-
Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer
NCT00607828 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver Transplantation
NCT06218420 ·Status: RECRUITING ·Phase: PHASE2
-
Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)
NCT02722395 ·Status: COMPLETED
-
Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer
NCT03408665 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy
NCT00026650 ·Status: RECRUITING
-
SBRT + TACE for Primary Hepatocellular Carcinoma
NCT00746655 ·Status: WITHDRAWN ·Phase: NA
-
Radiotherapy Versus no Intervention in Adult Patients With Hepatocellular Carcinoma Not Eligible for Transarterial Chemoembolization or Ablation Prior to Liver Transplant (RADBRI)
NCT03172559 ·Status: WITHDRAWN ·Phase: NA
-
Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma
NCT04996914 ·Status: RECRUITING ·Phase: NA
-
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
NCT00976898 ·Status: COMPLETED ·Phase: NA
-
Investigation of Respiratory-related Tumour Motion in Liver Cancer Patients Undergoing SBRT Using Audiovisual Biofeedback
NCT04323618 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT00777894 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stereotactic Radiosurgery for Patients With Hepatic Metastases.
NCT00547677 ·Status: COMPLETED ·Phase: PHASE1
-
Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver Cancer
NCT03203304 ·Status: TERMINATED ·Phase: PHASE1